Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Yuanfudao stays course to raise $1bn
Tencent-backed online learning platform developer Yuanfudao was reportedly valued at $15.5bn post-money in its series G2 round.
Dingdang Kuaiyao digs up $150m
Softbank China and Sinopharm-CICC Capital returned for a series B-plus round after backing the online pharmacy's 2019 series B.
Compass Therapeutics directs itself to IPO filing
The immuno-oncology therapy developer filed to raise up to $50m, two years after securing money from investors including Biomed Realty and Alexandria Real Estate Equities.
Tarana tacks on $30m
Liberty Latin America Ventures and Liberty Global Ventures joined the investors in Tarana Wireless which is preparing to launch its residential broadband service.
4iQ forces through $30m series C
The Telefónica-backed cyber intelligence producer took its total funding past the $60m mark in a round co-led by ForgePoint Capital and Benhamou Global Ventures.
FinLocker meets TransUnion in $20m round
TransUnion has contributed to a series A-1 round for the financial management and advice app developer as part of a commercial partnership deal.
Klar clasps $15m in series A round
The Mexico-based challenger bank secured $15m in a Prosus Ventures-led round that included the Santander-sponsored Mouro Capital.
Qualcomm checks out AiFi
Qualcomm Ventures participated in a round of undisclosed size that boosted the atuonomous retail technology provider's overall funding to $30m.

News Continued

Prometheus finds Utopia
Prometheus Group has paid an undisclosed amount for the data management software producer, allowing Liberty Mutual to exit.
Aumni augments series A round
The investment analytics system developer added $3m from investors including Donnelley Financial Solutions, DLA Piper and Orrick to $10m it raised in February.
Astellas takes an Iota in acquisition deal
The bioelectronic medicine developer has been snapped up by Astellas, two years after the latter took part in its series A round.
Didi Chuxing deliberates over 2021 IPO
The corporate-backed on-demand ride provider is reportedly looking at Hong Kong for a possible initial public offering, which could be preceded by more funding.
VectivBio reconnects to Novo for $110m
The short bowel syndrome therapy developer has added $110m to the $35m with which it emerged from stealth in January.
Hyperscience hits series D with $80m
TD Ameritrade and QBE-backed automation software producer Hyperscience has now raised in excess of $190m in total, Tiger Global Management leading its latest round.

Editor's Picks

Aligos accesses public markets with $150m
Roche and Novo-backed small molecule therapy developer Aligos Therapeutics has floated in an initial public offering priced in the middle of its range.
Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Opendoor welcomes reverse merger
Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.
test reg